Abstract
Introduction
Resistin is a proinflammatory hormone recently proposed as a sepsis biomarker. Our aim was to evaluate the diagnostic and prognostic values of this marker in neonatal sepsis.
Methods
This is a prospective observational study that includes 60 term and late preterm neonates with proven and possible sepsis besides 30 healthy controls. Resistin and other biomarkers, like C-reactive protein (CRP), were measured within 2 h of neonatal intensive care unit (NICU) admission. Infants were monitored and the primary outcome was 30-day mortality.
Results
Resistin was higher among septic neonates compared with controls (P<0.001). Resistin had an area under the receiver operating characteristic (ROC) curve of 0.994 for differentiating septic infants from controls. The area under the curve (AUC) for differentiating infants with culture-proven sepsis from controls was 0.999 compared with an AUC of 1 for CRP. The other markers, like platelet count, were inferior to resistin and CRP. Resistin was positively correlated with CRP [Spearman’s correlation coefficient (rs)=0.55, P<0.001]. No significant differences in resistin levels were noted between survivors and non-survivors but resistin was higher among infants with severe sepsis (P=0.015) and among those who needed mechanical ventilation (P<0.001).
Conclusion
Resistin is useful for the diagnosis of neonatal sepsis. Resistin failed to predict mortality but was associated with indicators of disease severity.
Author’s statement
Conflict of interest: Authors state no conflict of interest.
Material and methods: Informed consent: Informed consent has been obtained from all individuals included in this study.
Ethical approval: The research related to human subject use has complied with all the relevant national regulations, and institutional policies, and is in accordance with the tenets of the Helsinki Declaration, and has been approved by the authors’ institutional review board or equivalent committee.
References
[1] Blencowe H, Vos T, Lee AC, Philips R, Lozano R, Alvarado MR, et al. Estimates of neonatal morbidities and disabilities at regional and global levels for 2010: introduction, methods overview, and relevant findings from the Global Burden of Disease study. Pediatr Res. 2013;74:4–16.10.1038/pr.2013.203Search in Google Scholar
[2] Cortese F, Scicchitano P, Gesualdo M, Filaninno A, De Giorgi E, Schettini F, et al. Early and late infections in newborns: where do we stand? A review. Pediatr Neonatol. 2016;57:265–73.10.1016/j.pedneo.2015.09.007Search in Google Scholar
[3] Chauhan N, Tiwari S, Jain U. Potential biomarkers for effective screening of neonatal sepsis infections: an overview. Microb Pathog. 2017;107:234–42.10.1016/j.micpath.2017.03.042Search in Google Scholar
[4] Ellahony DM, El-Mekkawy MS, Farag MM. A study of red cell distribution width in neonatal sepsis. Pediatr Emerg Care. 2017. DOI: 10.1097/PEC.0000000000001319, PMID:29084071 [Epub ahead of print].10.1097/PEC.0000000000001319Search in Google Scholar
[5] Alkan Ozdemir S, Arun Ozer E, Ilhan O, Sutcuoglu S. Can neutrophil to lymphocyte ratio predict late-onset sepsis in preterm infants? J Clin Lab Anal. 2017. DOI: 10.1002/jcla.22338 [Epub ahead of print].10.1002/jcla.22338Search in Google Scholar
[6] Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2–8.10.1097/01.PCC.0000149131.72248.E6Search in Google Scholar
[7] Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307–12.10.1038/35053000Search in Google Scholar
[8] Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 2003;300:472–6.10.1016/S0006-291X(02)02841-3Search in Google Scholar
[9] Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med. 2010;14:1419–31.10.1111/j.1582-4934.2009.00899.xSearch in Google Scholar PubMed PubMed Central
[10] Lee S, Lee HC, Kwon YW, Lee SE, Cho Y, Kim J, et al. Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes. Cell Metab. 2014;19:484–97.10.1016/j.cmet.2014.01.013Search in Google Scholar PubMed PubMed Central
[11] Filková M, Haluzík M, Gay S, Senolt L. The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol. 2009;133:157–70.10.1016/j.clim.2009.07.013Search in Google Scholar
[12] Tavladaki T, Spanaki AM, Dimitriou H, Kondili E, Choulaki C, Georgopoulos D, et al. Similar metabolic, innate immunity, and adipokine profiles in adult and pediatric sepsis versus systemic inflammatory response syndrome — a pilot study. Pediatr Crit Care Med. 2017;18:e494–505.10.1097/PCC.0000000000001300Search in Google Scholar
[13] Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score, expanded to include extremely premature infants. Ballard J Pediatr. 1991;119:417–23.10.1016/S0022-3476(05)82056-6Search in Google Scholar
[14] Lean WL, Kamlin CO, Garland SM, Jacobs SE. Stable rates of neonatal sepsis in a tertiary neonatal unit. J Paediatr Child Health. 2015;51:294–9.10.1111/jpc.12715Search in Google Scholar PubMed
[15] Buttery JP. Blood cultures in newborns and children: optimising an everyday test. Arch Dis Child Fetal Neonatal Ed. 2002;87:F25–8.10.1136/fn.87.1.F25Search in Google Scholar
[16] Poggi C, Bianconi T, Gozzini E, Generoso M, Dani C. Presepsin for the detection of late onset sepsis in preterm newborns. Pediatrics. 2015;135:68–75.10.1542/peds.2014-1755Search in Google Scholar PubMed
[17] Cekmez F, Canpolat FE, Cetinkaya M, Aydinöz S, Aydemir G, Karademir F, et al. Diagnostic value of resistin and visfatin, in comparison with C-reactive protein, procalcitonin and interleukin-6 in neonatal sepsis. Eur Cytokine Netw. 2011;22:113–7.10.1684/ecn.2011.0283Search in Google Scholar PubMed
[18] Aliefendioglu D, Gürsoy T, Çağlayan O, Aktaş A, Ovalı F. Can resistin be a new indicator of neonatal sepsis? Pediatr Neonatol. 2014;55:53–7.10.1016/j.pedneo.2013.04.012Search in Google Scholar PubMed
[19] Gokmen Z, Ozkiraz S, Kulaksizoglu S, Kilicdag H, Ozel D, Ecevit A, et al. Resistin – a novel feature in the diagnosis of sepsis in premature neonates. Am J Perinatol. 2013;30:513–7.10.1055/s-0032-1329182Search in Google Scholar PubMed
[20] Sundén-Cullberg J, Nyström T, Lee ML, Mullins GE, Tokics L, Andersson J, et al. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit Care Med. 2007;35:1536–42.10.1097/01.CCM.0000266536.14736.03Search in Google Scholar PubMed
[21] Hillenbrand A, Knippschild U, Weiss M, Schrezenmeier H, Henne-Bruns D, Huber-Lang M, et al. Sepsis induced changes of adipokines and cytokines – septic patients compared to morbidly obese patients. BMC Surgery. 2010;10:26.10.1186/1471-2482-10-26Search in Google Scholar PubMed PubMed Central
[22] Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care. 2009;13:R95.10.1186/cc7925Search in Google Scholar PubMed PubMed Central
[23] Vassiliadi DA, Tzanela M, Kotanidou A, Orfanos SE, Nikitas N, Armaganidis A, et al. Serial changes in adiponectin and resistin in critically ill patients with sepsis: associations with sepsis phase, severity, and circulating cytokine levels. J Crit Care. 2012;27:400–9.10.1016/j.jcrc.2012.04.007Search in Google Scholar PubMed
[24] Liu KT, Liu YH, Lin CY, Tsai MJ, Hsu YL, Yen MC, et al. Serum neutrophil gelatinase-associated lipocalin and resistin are associated with dengue infection in adults. BMC Infect Dis. 2016;16:441.10.1186/s12879-016-1759-9Search in Google Scholar PubMed PubMed Central
[25] Goyette RE, Key NS, Ely EW. Hematologic changes in sepsis and their therapeutic implications. Semin Respir Crit Care Med. 2004;25:645–59.10.1055/s-2004-860979Search in Google Scholar PubMed
[26] Ahmad S, Khalid R. Blood glucose levels in neonatalsepsis and probable sepsis and its association with mortality. J Coll Physicians Surg Pak. 2012;22:15–8.Search in Google Scholar
[27] Macdonald SPJ, Bosio E, Neil C, Arendts G, Burrows S, Smart L, et al. Resistin and NGAL are associated with inflammatory response, endothelial activation and clinical outcomes in sepsis. Inflamm Res. 2017;66:611–9.10.1007/s00011-017-1043-5Search in Google Scholar PubMed
©2018 Walter de Gruyter GmbH, Berlin/Boston
